MYRIAD GENETICS, INC. INDENTURE Dated as of DEBT SECURITIES TrusteeIndenture • November 8th, 2023 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledNovember 8th, 2023 Company Industry JurisdictionWHEREAS, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of unsecured debentures, notes, bonds or other evidences of indebtedness (the “Securities”) in an unlimited aggregate principal amount to be issued from time to time in one or more series as provided in this Indenture; and